Redox cycling of potential antitumor aziridinyl quinones
- 31 December 1992
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 13 (6) , 599-608
- https://doi.org/10.1016/0891-5849(92)90034-e
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Mechanism(s) of bioreductive activation: The example of diaziquinone (AZQ)Free Radical Biology & Medicine, 1989
- DNA alkylation and formation of DNA interstrand cross-links by potential antitumour 2,5-bis(1-aziridinyl)-1,4-benzoquinonesChemico-Biological Interactions, 1989
- Comparison of the effects of superoxide dismutase and cytochrome c on luminol chemiluminescence produced by xanthine oxidase-catalyzed reactionsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
- The reduction of anti-tumour diaziridinyl benzoquinonesBiochimica et Biophysica Acta (BBA) - General Subjects, 1987
- Interactions of anticancer quinone drugs, aclacinomycin A, adriamycin, carbazilquinone, and mitomycin C, with NADPH-cytochrome P-450 reductase, xanthine oxidase and oxygen.Journal of Pharmacobio-Dynamics, 1986
- Efficiency of chelated iron compounds as catalysts for the Haber-Weiss reactionJournal of Free Radicals in Biology & Medicine, 1985
- Reactions of the semiquinone free radicals of anti‐tumour agents with oxygen and iron complexesFEBS Letters, 1985
- Spectrophotometric determination of hydrogen peroxide and organic hydropheroxides at low concentrations in aqueous solutionAnalytica Chimica Acta, 1983
- Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 2Journal of Medicinal Chemistry, 1976
- Antileukemic Agents. II. New 2, 5-Bis (1-aziridinyl)-p-benzoquinone DerivativesCHEMICAL & PHARMACEUTICAL BULLETIN, 1972